Graphene: safe or toxic? The two faces of the medal.

Graphene is considered the future revolutionary material. For its development, it is of fundamental importance to evaluate the safety profile and the impact on health. Graphene is part of a bigger family which has been identified as the graphene family nanomaterials (GFNs). Clarifying the existence of multiple graphene forms allows better understanding the differences between the components and eventually correlating their biological effects to the physicochemical characteristics of each structure. Some in vitro and in vivo studies clearly showed no particular risks, while others have indicated that GFNs might become health hazards. This Minireview critically discusses the recent studies on the toxicity of GFNs to provide some perspective on the possible risks to their future development in materials and biomedical sciences.

[1]  Hua Zhang,et al.  Graphene-based composites. , 2012, Chemical Society reviews.

[2]  G. Eda,et al.  Graphene oxide as a chemically tunable platform for optical applications. , 2010, Nature chemistry.

[3]  Qing Huang,et al.  Effect of graphene oxide on undifferentiated and retinoic acid-differentiated SH-SY5Y cells line. , 2012, Nanoscale.

[4]  Feng Zhao,et al.  Low-toxic and safe nanomaterials by surface-chemical design, carbon nanotubes, fullerenes, metallofullerenes, and graphenes. , 2011, Nanoscale.

[5]  Chunhai Fan,et al.  Graphene-based antibacterial paper. , 2010, ACS nano.

[6]  Zhuang Liu,et al.  Nano-graphene oxide for cellular imaging and drug delivery , 2008, Nano research.

[7]  Qiyuan He,et al.  Graphene-based materials: synthesis, characterization, properties, and applications. , 2011, Small.

[8]  Liangzhu Feng,et al.  Graphene in biomedicine: opportunities and challenges. , 2011, Nanomedicine.

[9]  R. Advíncula,et al.  Graphene nanocomposite for biomedical applications: fabrication, antimicrobial and cytotoxic investigations , 2012, Nanotechnology.

[10]  Yue Cui,et al.  Biomimetic peptide nanosensors. , 2012, Accounts of chemical research.

[11]  Jozef Adamcik,et al.  Biodegradable nanocomposites of amyloid fibrils and graphene with shape-memory and enzyme-sensing properties. , 2012, Nature nanotechnology.

[12]  D. Rodrigues,et al.  Toxicity of a polymer-graphene oxide composite against bacterial planktonic cells, biofilms, and mammalian cells. , 2012, Nanoscale.

[13]  Antonio Nunes,et al.  Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. , 2011, The American journal of pathology.

[14]  J. Klein-Seetharaman,et al.  The enzymatic oxidation of graphene oxide. , 2011, ACS nano.

[15]  Yu-Chen Hu,et al.  Simultaneous induction of autophagy and toll-like receptor signaling pathways by graphene oxide. , 2012, Biomaterials.

[16]  Bing Yan,et al.  Size-dependent cell uptake of protein-coated graphene oxide nanosheets. , 2012, ACS applied materials & interfaces.

[17]  Djordje Klisic,et al.  Graphene quantum dots as autophagy-inducing photodynamic agents. , 2012, Biomaterials.

[18]  Deepthy Menon,et al.  Hemocompatibility and macrophage response of pristine and functionalized graphene. , 2012, Small.

[19]  Remo Guidieri.  Res , 1995, RES: Anthropology and Aesthetics.

[20]  Chi Bun Ching,et al.  Comparative protein profile of human hepatoma HepG2 cells treated with graphene and single-walled carbon nanotubes: an iTRAQ-coupled 2D LC-MS/MS proteome analysis. , 2011, Toxicology letters.

[21]  E. Borowiak‐Palen,et al.  Synthesis, dispersion, and cytocompatibility of graphene oxide and reduced graphene oxide. , 2012, Colloids and surfaces. B, Biointerfaces.

[22]  Zhuang Liu,et al.  PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. , 2008, Journal of the American Chemical Society.

[23]  Balaji Sitharaman,et al.  Cell specific cytotoxicity and uptake of graphene nanoribbons. , 2013, Biomaterials.

[24]  Wei Wei,et al.  The role of the lateral dimension of graphene oxide in the regulation of cellular responses. , 2012, Biomaterials.

[25]  Debabrata Dash,et al.  Amine-modified graphene: thrombo-protective safer alternative to graphene oxide for biomedical applications. , 2012, ACS nano.

[26]  Omid Akhavan,et al.  Toxicity of graphene and graphene oxide nanowalls against bacteria. , 2010, ACS nano.

[27]  Kostas Kostarelos,et al.  The long and short of carbon nanotube toxicity , 2008, Nature Biotechnology.

[28]  Yang Xu,et al.  Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. , 2010, ACS nano.

[29]  Andre K. Geim,et al.  Electric Field Effect in Atomically Thin Carbon Films , 2004, Science.

[30]  L. Dai,et al.  Can graphene oxide cause damage to eyesight? , 2012, Chemical research in toxicology.

[31]  K. Novoselov,et al.  A roadmap for graphene , 2012, Nature.

[32]  W. Mai,et al.  The use of polyethyleneimine-modified reduced graphene oxide as a substrate for silver nanoparticles to produce a material with lower cytotoxicity and long-term antibacterial activity , 2012 .

[33]  M. S. Sarto,et al.  Graphite nanoplatelets and Caenorhabditis elegans: insights from an in vivo model. , 2012, Nano letters.

[34]  Petr Král,et al.  Sandwiched graphene--membrane superstructures. , 2010, ACS nano.

[35]  Agnes B Kane,et al.  Biological interactions of graphene-family nanomaterials: an interdisciplinary review. , 2012, Chemical research in toxicology.

[36]  Kostas Kostarelos,et al.  Safety considerations for graphene: lessons learnt from carbon nanotubes. , 2013, Accounts of chemical research.

[37]  Hao Hong,et al.  Graphene: a versatile nanoplatform for biomedical applications. , 2012, Nanoscale.

[38]  Abhishek Sahu,et al.  A stimuli-sensitive injectable graphene oxide composite hydrogel. , 2012, Chemical communications.

[39]  Ken Donaldson,et al.  Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties. , 2012, ACS nano.

[40]  Yanli Chang,et al.  In vitro toxicity evaluation of graphene oxide on A549 cells. , 2011, Toxicology letters.

[41]  Kian Ping Loh,et al.  The chemistry of graphene , 2010 .

[42]  A. Pandey,et al.  Toxicity of graphene in normal human lung cells (BEAS-2B). , 2011, Journal of biomedical nanotechnology.

[43]  Jing Kong,et al.  Lateral dimension-dependent antibacterial activity of graphene oxide sheets. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[44]  Kai Yang,et al.  In vitro and in vivo behaviors of dextran functionalized graphene , 2011 .

[45]  Xingfa Gao,et al.  Unraveling Stress‐Induced Toxicity Properties of Graphene Oxide and the Underlying Mechanism , 2012, Advanced materials.

[46]  Kai Yang,et al.  Nano-graphene in biomedicine: theranostic applications. , 2013, Chemical Society reviews.

[47]  J. Tour,et al.  Pristine graphite oxide. , 2012, Journal of the American Chemical Society.

[48]  Mark C Hersam,et al.  Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung. , 2011, Nano letters.

[49]  He Shen,et al.  Biomedical Applications of Graphene , 2012, Theranostics.

[50]  W. N. Chen,et al.  Cytotoxicity evaluation of oxidized single-walled carbon nanotubes and graphene oxide on human hepatoma HepG2 cells: an iTRAQ-coupled 2D LC-MS/MS proteome analysis. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[51]  Poramane Chiochan,et al.  Synthesis and antifungal activity of reduced graphene oxide nanosheets , 2012 .

[52]  Omid Akhavan,et al.  Escherichia coli bacteria reduce graphene oxide to bactericidal graphene in a self-limiting manner , 2012 .

[53]  Chunhai Fan,et al.  Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration , 2011 .

[54]  Ying Liu,et al.  The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways. , 2012, Biomaterials.

[55]  Gil Gonçalves,et al.  The effects of graphene oxide nanosheets localized on F-actin filaments on cell-cycle alterations. , 2013, Biomaterials.

[56]  Christy L Haynes,et al.  Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. , 2011, ACS applied materials & interfaces.

[57]  Yanli Chang,et al.  Effect of size and dose on the biodistribution of graphene oxide in mice. , 2012, Nanomedicine.

[58]  Jing Kong,et al.  Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress. , 2011, ACS nano.

[59]  Craig A. Poland,et al.  Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. , 2008, Nature nanotechnology.

[60]  M. Prato,et al.  Translocation mechanisms of chemically functionalised carbon nanotubes across plasma membranes. , 2012, Biomaterials.

[61]  K Kostarelos,et al.  Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. , 2009, Nature nanotechnology.

[62]  Oscar N. Ruiz,et al.  Graphene oxide: a nonspecific enhancer of cellular growth. , 2011, ACS nano.

[63]  A. Ganguli,et al.  Enhanced functionalization of Mn2O3@SiO2 core-shell nanostructures , 2011, Nanoscale research letters.

[64]  Rodolfo Cruz-Silva,et al.  Flash reduction and patterning of graphite oxide and its polymer composite. , 2009, Journal of the American Chemical Society.

[65]  A. Olszyna,et al.  Recent advances in graphene family materials toxicity investigations , 2012, Journal of Nanoparticle Research.

[66]  Kai Yang,et al.  Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. , 2010, Nano letters.

[67]  Kai Yang,et al.  In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. , 2011, ACS nano.

[68]  Deepthy Menon,et al.  Differential nano-bio interactions and toxicity effects of pristine versus functionalized graphene. , 2011, Nanoscale.

[69]  S. Shrivastava,et al.  Thrombus inducing property of atomically thin graphene oxide sheets. , 2011, ACS nano.